Gene Query: AVL9

Dataset Description Geneva Score
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 33.65
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 31.12
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 26.26
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 25.65
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 24.89
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 22.87
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 22.21
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 22.21
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 21.93
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 21.93
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 21.86
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 21.56
CD73 knockdown effect in pancreatic cancer cell lines 21.27
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 20.49
RIG-I and MDA5 fRIP during KSHV lytic reactivation 20.44
RNA-seq of shEZH2 cells 20.07
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 19.89
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 19.35
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 19.01
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 18.23
Transcriptome analysis in Neobractatin treated cells 17.19
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 17.08
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 16.89
The regulartory role of ZCCHC24 in splicing machinery 16.87
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 16.7
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 16.7
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 16.29
Effect of mitochondria deficiency on senescence-associated gene expression 16.27
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 15.94
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 15.94
Maturation of human iNSCs 15.34
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 15.03
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 14.63
TFAP2C signalling in human fibroblasts 14.39
Altering cancer transcriptomes using epigenomic inhibitors 14.18
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 14.18
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 14.16
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 13.94
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 13.83
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 13.55
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 13.55
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 13.09
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 13.04
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 12.99
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 12.94
Genome wide miR-191 target profile determined by RIP and gene expression profiling 12.94
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 12.8
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 12.57
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 12.54
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 12.46
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 12.39
RNA-Seq analysis of breast cancer cells after shikonin treatment 12.32
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 12.19
MYC dependent mRNA translation shapes gene expression and cell biology 12.19
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 12.1
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 11.89
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.82
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 11.72
Targeting MTHFD2 in Acute Myeloid Leukemia 11.51
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 11.51
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 11.47
Knockdown of ADNP in HCT116 colon cancer cells 11.46
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 11.39
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 11.25
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 11.24
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 11.24
SUV420H2 knockdown in PANC-1 11.2
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 11.07
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 10.86
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 10.83
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 10.76
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 10.53
Transcriptomic analysis of LSD1 10.46
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 10.4
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 10.39
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 10.29
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 10.2
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 10.09
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 10.07
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 10.03
Illumina Total RNA-seq in HeLa 9.94
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 9.9
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 9.84
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 9.82
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 9.8
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 9.73
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 9.73
Cajal bodies are linked to genome conformation [RNA-Seq] 9.67
Cajal bodies are linked to genome conformation 9.67
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 9.53
RNA-seq analysis of AML cells in response to ASLAN003 9.5
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 9.47
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 9.46
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.42
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.42
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 9.34
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 9.34
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 9.25
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 9.22
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 9.16
R430: A potent inbibitor of DNA and RNA viruses 9.14
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 9.12
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 8.84
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 8.81
Comparison of microRNA Profiling Platforms 8.69
Comparison of microRNA Profiling Platforms (HTS) 8.69
miR941 overexpression experiment 8.67
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 8.62
CDK12 mediated transcriptional regulation in U2OS cells 8.58
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 8.58
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 8.56
Single-cell analysis of human kidney organoids 8.47
ARID1A and ARID1B loss in HCT116 cells 8.43
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 8.36
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 8.33
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 8.24
RNA-seq of human aneuploid cell lines with Trisomy 21 8.12
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 8.06
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 8.03
RNA-seq of YB5 cells treated with Proscillaridin A 8.03
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 7.95
Hijacking of stress response machinery by oncogenes in acute leukaemia 7.95
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 7.93
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.87
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 7.85
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 7.8
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 7.8
Silencing SPIB in attached and floating state of H1703 lung cancer cells 7.8
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 7.77
HNF1 regulates critical functions of the human epididymis epithelium. 7.77
Impact of dieldrin on transcription in Jurkat T cells 7.71
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 7.69
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 7.62
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 7.61
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 7.57
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.55
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.55
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 7.55
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 7.53
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 7.5
Hepatitis C virus functionally sequesters miR-122 7.5
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 7.47
Identification of Nrf2 regulated genes by RNA sequencing 7.45
Nrf2 regulated genes in A549 cells 7.45
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 7.42
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 7.4
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.38
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 7.34
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 7.33
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 7.3
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.3
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 7.29
RNA-seq analyses of human prostate cancer cells 7.26
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 7.24
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 7.24
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 7.22
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 7.22
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 7.21
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 7.2
LINE-2 transposable elements are a source of functional human microRNAs and target sites 7.19
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 7.18
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 7.17
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 7.17
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 7.12
Identifying the molecular mode of action of itraconazole in colorectal cancer 7.11
The transcriptome effect of overexpressing EZH2 in MCF7 7.08
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.07
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 7.07
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.99
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 6.99
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.98
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 6.95
Oncogenic roles of ARID5B in T-ALL 6.95
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.94
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 6.93
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 6.93
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 6.91
snRNAs as regulators of alternative splicing 6.9
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 6.89
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.88
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.84
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 6.81
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 6.77
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 6.76
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 6.68
Total RNA sequencing of WT intestinal orgaonids. 6.68
Effect of PBK knockdown on C4-2 cell transcriptome 6.65
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 6.63
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 6.62
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 6.62
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 6.61
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 6.6
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 6.57
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.57
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 6.5
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 6.45
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 6.45
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 6.45
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 6.44
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 6.41
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 6.41
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 6.4
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 6.39
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 6.37
Genome-wide analysis of the Integrator complex 6.37
Genome-wide analysis of the Integrator complex (HTS) 6.37
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 6.36
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 6.36
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 6.35
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 6.34
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 6.34
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 6.33
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 6.32
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.28
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 6.26
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.25
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 6.22
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 6.2
LncRNA expression profiling of ischemic stroke patients 6.19
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.15
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 6.11
Conservative alteration of chromosomal expression pattern across human solid tumor types 6.08
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 6.04
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.04
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 6.0
ARS2 is a general suppressor of pervasive transcription [RNAseq] 5.99
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 5.94
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 5.92
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 5.9
Exploring ILF2 regulatory genes by next-generation sequencing 5.89
BASP1 modifies the Tamoxifen response 5.87
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 5.86
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 5.86
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 5.81
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 5.81
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 5.79
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 5.78
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 5.78
Capturing the Interactome of Newly Transcribed RNA 5.78
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.78
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 5.77
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 5.77
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 5.76
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 5.76
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 5.75
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 5.75
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 5.73
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 5.72
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.69
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 5.67
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 5.63
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 5.62
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 5.62
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 5.61
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 5.6
Microprocessor mediates transcription termination in long noncoding microRNA genes 5.58
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 5.55
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 5.55
Gene expression in GBM with Cav3.2 inhibition 5.51
Gene expression profile in breast cancer cell lines using RNA sequencing 5.51
Searching for target genes of miR-508/509/506/514 in HCT116 cells 5.49
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 5.48
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 5.46
Metastasis in triple-negative breast cancer 5.46
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 5.44
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 5.43
K562 polyA RNA-Seq 5.4
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 5.39
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 5.38
Induced DNA demethylation, genome instability and transcription 5.38
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 5.31
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 5.3
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 5.27
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.24
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 5.21
RNA-sequencing 5.19
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 5.12
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 5.11
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 5.08
N6-methyladenine DNA Modification in Glioblastoma 5.08
Transcriptomic analysis of ERR alpha orphan nuclear receptor 5.07
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.07
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 5.05
Effect of drugs on transcriptomic profiles 5.0
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 4.98
Regulation of highly expressed hCINAP on translatome 4.89
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.87
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 4.84
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 4.84
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.83
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.82
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 4.81
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 4.81
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.79
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 4.79
Seletive inhibition of CDK9 in DLBCL cell lines 4.78
6mer seed toxicity in tumour suppressive microRNAs 4.78
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 4.77
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 4.72
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 4.72
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 4.72
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 4.71
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.64
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.56
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 4.53
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 4.47
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.26
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 4.23
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 4.22
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 4.2
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 4.2
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 4.18
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 4.15
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 4.15
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 4.14
In situ CAPTURE of chromatin interactions by biotinylated dCas9 4.14
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 4.09
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 4.08
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 4.06
Gene expression profile in breast cancer cells 4.05
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 4.05
LncRNA-GAS5 negative regulation of YAP-target genes expression 4.05
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 4.02
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.01
4sU-seq of HFF exposed to salt and heat stress 3.96
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.94
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.94
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 3.91
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 3.91
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.89
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 3.86
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 3.85
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 3.84
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.84
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.79
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 3.72
Characterization of parental and rociletinib-resistant derived H1975 cell lines 3.68
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.67
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 3.65
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.65
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.63
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.63
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.63
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.56
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 3.54
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.49
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 3.48
NR2F2 study 3.48
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 3.48
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 3.47
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 3.47
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.44
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 3.39
Role of COP1 on MAP kinase transcriptional output in melanoma 3.28
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 3.28
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 3.25
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.13
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.12
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.08
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 3.08
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.95
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.95
RNAseq in Alzheimer's Disease patients 2.87
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.87
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.81
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.81
The cohesin release factor WAPL restricts chromatin loop extension. 2.81
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.77
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.77
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.69
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 2.68
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 2.66
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 2.65
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.62
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.62
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.62
Loss of CREBBP results in gene expression repression in lymphoma cells 2.56
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.56
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.47
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.47
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 2.45
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.45
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.44
Transcriptome profiling of 5 human adenocarcinoma cell lines 2.44
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.34
Argonaute proteins couple chromatin silencing to alternative splicing 2.32
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 2.32
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.25
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.21
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.19
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.15
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 2.12
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 2.12
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.09
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.09
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.09
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.06
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.03
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 2.02
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.01
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 1.93
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.92
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.79
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.78
UV_24h_GRO-Seq 1.77
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.76
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.74
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.73
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.67
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.66
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.64
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.64
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.55
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.55
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.54
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.54
Functional significance of the HIV-1 Tat signature amino acid residues 1.49
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.45
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 1.45
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 1.44
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 1.44
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.41
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.37
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.32
The role of the Calcium-Sensing receptor in colorectal cancer 1.32
Myc activation coordinates gene transcription and protein translation responses 1.32
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.31
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.31
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.22
Effects of transcription on genome - nuclear lamina interactions 1.22
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.2
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.19
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.19
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.16
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.14
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.1
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 1.1
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 1.06
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.04
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.04
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.03
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.02
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.01
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.94
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.93
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.93
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.92
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.91
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.91
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.88
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.87
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.85
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.77
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.73
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.7
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.67
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.65
Gene expression analysis of human hepatocellular cancers 0.64
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.63
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.63
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.59
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 0.54
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.53
Modulation of nonsense-mediated decay by rapamycin 0.51
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.5
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.48
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.48
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.48
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.47
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.47
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.47
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.45
Human Tfh cell RNA bulk sequencing 0.43
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.41
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.41
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.39
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.39
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.39
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.31
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.31
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.24
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.24
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.2
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.2
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.2
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.18
Transcriptomic profiling of human peripheral blood-derived mast cells 0.18
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.12
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.09
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.09
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.08
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.06
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.01
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.01
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.01
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.0
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.0
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation